Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: Results of the EPISTENT trial

被引:14
作者
Lincoff, AM [1 ]
机构
[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA
关键词
D O I
10.1067/mhj.2000.103743
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S46 / S52
页数:7
相关论文
共 23 条
[11]   Single bailout stenting for threatened coronary closure complicating balloon angioplasty: Acute and mid-term outcome [J].
Lau, KW ;
Gao, W ;
Ding, ZP ;
Kwok, V .
CORONARY ARTERY DISEASE, 1996, 7 (04) :327-333
[12]   Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors [J].
Lincoff, AM ;
Califf, RM ;
Moliterno, DJ ;
Ellis, SG ;
Ducas, J ;
Kramer, JH ;
Kleiman, NS ;
Cohen, EA ;
Booth, JE ;
Sapp, SK ;
Cabot, CF ;
Topol, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (05) :319-327
[13]   Intravascular ultrasound to discern device-specific effects and mechanisms of restenosis [J].
Mintz, GS ;
Popma, JJ ;
Hong, MK ;
Pichard, AD ;
Kent, KM ;
Satler, LF ;
Leon, MB .
AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 :18-22
[14]   LUMINAL NARROWING AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A STUDY OF CLINICAL, PROCEDURAL, AND LESIONAL FACTORS RELATED TO LONG-TERM ANGIOGRAPHIC OUTCOME [J].
RENSING, BJ ;
HERMANS, WRM ;
VOS, J ;
TIJSSEN, JGP ;
RUTCH, W ;
DANCHIN, N ;
HEYNDRICKX, GR ;
MAST, EG ;
WIJNS, W ;
SERRUYS, PW .
CIRCULATION, 1993, 88 (03) :975-985
[15]   Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery [J].
Risum, O ;
Abdelnoor, M ;
Svennevig, JL ;
Levorstad, K ;
Gullestad, L ;
Bjornerheim, R ;
Simonsen, S ;
NitterHauge, S .
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 30 (02) :71-75
[16]   INFLUENCE OF DIABETES-MELLITUS ON EARLY AND LATE OUTCOME AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
STEIN, B ;
WEINTRAUB, WS ;
GEBHART, SSP ;
COHENBERNSTEIN, CL ;
GROSSWALD, R ;
LIBERMAN, HA ;
DOUGLAS, JS ;
MORRIS, DC ;
KING, SB .
CIRCULATION, 1995, 91 (04) :979-989
[17]   Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade [J].
Topol, EJ ;
Lincoff, AM ;
Califf, RM ;
Tcheng, JE ;
Kleiman, NS ;
Adelman, AG ;
Burton, JR ;
Talley, JD ;
Ivanhoe, RJ ;
Ducas, C ;
Cheung, PK ;
Schick, U ;
Badard, D ;
Kramer, J ;
Leary, J ;
Snyder, H ;
Wilson, R ;
Dearen, M ;
Caramori, P ;
Webber, S ;
Taylor, J ;
Ferrando, T ;
Cohen, E ;
Balleza, L ;
Rouse, C ;
Hogg, N ;
Kelly, T ;
Alston, S ;
Webb, J ;
Buller, E ;
Ricci, DR ;
Mockman, S ;
Tanguay, JF ;
Poitras, AM ;
Timis, G ;
Davey, D ;
Coleman, P ;
Herrold-Runge, P ;
O'Neill, BJ ;
Foshey, K ;
Fitzgerald, N ;
Almond, D ;
Kostuk, W ;
White, J ;
Oskalns, R ;
Gottlieb, R ;
Koren, P ;
Palazzo, D ;
Azrin, M ;
Barry, MB .
LANCET, 1998, 352 (9122) :87-92
[18]   RANDOMIZED TRIAL OF CORONARY INTERVENTION WITH ANTIBODY AGAINST PLATELET IIB/IIIA INTEGRIN FOR REDUCTION OF CLINICAL RESTENOSIS - RESULTS AT 6 MONTHS [J].
TOPOL, EJ ;
CALIFF, RM ;
WEISMAN, HF ;
ELLIS, SG ;
TCHENG, JE ;
WORLEY, S ;
IVANHOE, R ;
GEORGE, BS ;
FINTEL, D ;
WESTON, M ;
SIGMON, K ;
ANDERSON, KM ;
LEE, KL ;
WILLERSON, JT ;
SMITH, CR ;
WEISMAN, H .
LANCET, 1994, 343 (8902) :881-886
[19]  
Topol EJ, 1997, NEW ENGL J MED, V336, P1689
[20]   Restenosis rates in diabetic patients - A comparison of coronary stenting and balloon angioplasty in native coronary vessels [J].
VanBelle, E ;
Bauters, C ;
Hubert, E ;
Bodart, JC ;
Abolmaali, K ;
Meurice, T ;
McFadden, EP ;
Lablanche, JM ;
Bertrand, ME .
CIRCULATION, 1997, 96 (05) :1454-1460